HCV treatment in 2020: How to translate highly effective therapies into elimination strategies

The hepatitis C virus (HCV) is among the most common blood-borne infections worldwide and a major cause of cirrhosis and hepatocellular carcinoma. HCV was first identified in 1989. The current use of direct-acting antiviral agents (DAAs) to cure HCV reflects rapid diagnostic and therapeutic advances...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshuwaykh, Omar, Kwo, Paul Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349344/
https://www.ncbi.nlm.nih.gov/pubmed/35949441
http://dx.doi.org/10.14744/hf.2020.2020.0009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349344/
https://www.ncbi.nlm.nih.gov/pubmed/35949441
http://dx.doi.org/10.14744/hf.2020.2020.0009

Ejemplares similares